Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–42.

Article  PubMed  Google Scholar 

Epstein MA, Henle G, Achong BG, Barr YM. Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma. J Exp Med. 1965;121:761–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, et al. Outlooks on Epstein–Barr virus associated gastric cancer. Cancer Treat Rev. 2018;66:15–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Röcken C. Molecular classification of gastric cancer. Expert Rev Mol Diagn. 2017;17(3):293–301.

Article  PubMed  Google Scholar 

Shinozaki-Ushiku A, Kunita A, Fukayama M. Update on Epstein–Barr virus and gastric cancer (review). Int J Oncol. 2015;46(4):1421–34.

Article  CAS  PubMed  Google Scholar 

Bae J-M, Kim EH. Epstein–Barr Virus and gastric cancer risk: a meta-analysis with meta-regression of case-control studies. J Prev Med Public Health. 2016;49(2):97.

Article  PubMed  PubMed Central  Google Scholar 

Qiao Y-W, Zhao XQ, Liu J, Yang WJ. Clinicopathological features of Epstein–Barr virus-associated gastric carcinoma: a systematic review and meta-analysis. J BUON. 2019;24(3):1092–9.

PubMed  Google Scholar 

Liu X, Liu J, Qiu H, Kong P, Chen S, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, et al. Prognostic significance of Epstein–Barr virus infection in gastric cancer: a meta-analysis. BMC Cancer. 2015;15:782.

Article  PubMed  PubMed Central  Google Scholar 

Pyo JS, Kim NY, Kang DW. Clinicopathological significance of EBV-infected gastric carcinomas: a meta-analysis. Medicina. 2020;56(7):345.

Article  PubMed  PubMed Central  Google Scholar 

Gulley ML, Tang W. Laboratory assays for Epstein–Barr virus-related disease. J Mol Diagn. 2008;10(4):279–92.

Article  PubMed  PubMed Central  Google Scholar 

Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: an update. World J Gastroenterol. 2016;22(19):4619–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, Ochiai A, Rüschoff J, Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008;52(7):797–805.

Article  CAS  PubMed  Google Scholar 

Smyth EC, Wotherspoon A, Peckitt C, Gonzalez D, Hulkki-Wilson S, Eltahir Z, Fassan M, Rugge M, Valeri N, Okines A, et al. Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial. JAMA Oncol. 2017;3(9):1197–203.

Article  PubMed  Google Scholar 

Yang N, Wu Y, Jin M, Jia Z, Wang Y, Cao D, Qin L, Wang X, Zheng M, Cao X, et al. Microsatellite instability and Epstein–Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer. PeerJ. 2021;9:e11481.

Article  PubMed  PubMed Central  Google Scholar 

Puliga E, Corso S, Pietrantonio F, Giordano S. Microsatellite instability in GASTRIC CANCER: BETWEEN LIGHTS and shadows. Cancer Treat Rev. 2021;95:102175.

Article  PubMed  Google Scholar 

Guan WL, Ma Y, Cui YH, Liu TS, Zhang YQ, Zhou ZW, Xu JY, Yang LQ, Li JY, Sun YT, et al. The impact of mismatch repair status on prognosis of patients with gastric cancer: a multicenter analysis. Front Oncol. 2021;11:712760.

Article  PubMed  PubMed Central  Google Scholar 

Huang S-C, Ng K-F, Chen K-H, Hsu J-T, Liu K-H, Yeh T-S, Chen T-C. Prognostic factors in Epstein–Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis. Oncol Rep. 2014;32(2):530–8.

Article  PubMed  Google Scholar 

Shibata D, Hawes D, Stemmermann GN, Weiss LM. Epstein–Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prevent A Publ Am Assoc Cancer Res Cosponsored Am Soc Prevent Oncol. 1993;2(3):213–7.

CAS  Google Scholar 

Beltrán Gárate B, Camara A, Kapsoli Sánchez MDC, Castro Uriol D, Yábar Berrocal A. Impact of the Epstein Barr virus on gastric cancer in Peru. Rev Gastroenterol Peru. 2019;39(4):319–22.

PubMed  Google Scholar 

Hewitt LC, Inam IZ, Saito Y, Yoshikawa T, Quaas A, Hoelscher A, Bollschweiler E, Fazzi GE, Melotte V, Langley RE, et al. Epstein–Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: a large multi-centre study. Eur J Cancer. 2018;94:104–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nogueira C, Mota M, Gradiz R, Cipriano MA, Caramelo F, Cruz H, Alarcão A, Oliveira F, Martinho F, et al. Prevalence and characteristics of Epstein–Barr virus-associated gastric carcinomas in Portugal. Infect Agent Cancer. 2017;12:41.

Article  PubMed  PubMed Central  Google Scholar 

Shen H, Zhong M, Wang W, Liao P, Yin X, Rotroff D, Knepper TC, McLeod HL, Zhou C, Xie S, et al. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients. Clin Chim Acta. 2017;471:216–21.

Article  CAS  PubMed  Google Scholar 

Ramos M, Pereira MA, Amorim LC, de Mello ES, Faraj SF, Ribeiro U, Hoff PMG, Cecconello I, de Castria TB. Gastric cancer molecular classification and adjuvant therapy: is there a different benefit according to the subtype? J Surg Oncol. 2020;121(5):804–13.

CAS  PubMed  Google Scholar 

Baek DW, Kang BW, Kim JG. The predictive value of Epstein–Barr virus-positivity in patients undergoing gastrectomy followed by adjuvant chemotherapy. Chonnam Med J. 2018;54(3):173–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Beek J, Zur-Hausen A, Klein-Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22(4):664–70.

Article  PubMed  Google Scholar 

Qiu MZ, He CY, Yang DJ, Zhou DL, Zhao BW, Wang XJ, Yang LQ, Lu SX, Wang FH, Xu RH. Observational cohort study of clinical outcome in Epstein–Barr virus associated gastric cancer patients. Ther Adv Med Oncol. 2020;12:1758835920937434.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J-N, He D, Tang F, Shao C-K. Epstein–Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol. 2012;46(4):262–71.

Article  CAS  PubMed  Google Scholar 

Burgess DE, Woodman CB, Flavell KJ, Rowlands DC, Crocker J, Scott K, Biddulph JP, Young LS, Murray PG. Low prevalence of Epstein–Barr virus in incident gastric adenocarcinomas from the United Kingdom. Br J Cancer. 2002;86(5):702–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein–Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137(3):824–33.

Article  PubMed  Google Scholar 

Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y. Meta-analysis of the relationship between Epstein–Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci China Life Sci. 2010;53(4):524–30.

Article  PubMed  Google Scholar 

Camargo MC, Koriyama C, Matsuo K, Kim W-H, Herrera-Goepfert R, Liao LM, Yu J, Carrasquilla G, Sung JJY, Alvarado-Cabrero I, et al. Case-case comparison of smoking and alcohol risk associations with Epstein–Barr virus-positive gastric cancer. Int J Cancer. 2014;134(4):948–53.

Article  CAS  PubMed  Google Scholar 

Suzuki T, Matsuo K, Ito H, Sawaki A, Hirose K, Wakai K, Sato S, Nakamura T, Yamao K, Ueda R, et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med. 2006;119(3):217–24.

Article  PubMed  Google Scholar 

Saito M, Kono K. Landscape of EBV-positive gastric cancer. Gastr Cancer Offic J Int Gastr Cancer Assoc Jpn Gastr Cancer Assoc. 2021;24(5):983–9.

CAS  Google Scholar 

Sun K, Jia K, Lv H, Wang SQ, Wu Y, Lei H, Chen X. EBV-positive gastric cancer: current knowledge and future perspectives. Front Oncol. 2020;10:583463.

Article  PubMed  PubMed Central  Google Scholar